Title: Martinez-Moreno JM, et al.In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/beta-catenin activation.Am J Physiol Renal Physiol. 2012 Aug 8.
Title: Ari E, Kedrah AE, Alahdab Y, Bulut G, Eren Z, Baytekin O, Odabasi D.Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model.Br J Radiol. 2012 Aug;85(1016):1038-43.
Title: Meems LM, Cannon MV, Mahmud H, Voors AA, van Gilst WH, Silljé HH, Ruifrok WP, de Boer RA.The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.J Steroid Biochem Mol Biol. 2012 Jul 16;132(3-5):282-289.
Title: Blanco-García R, et al.Microalbuminuria, another use for paricalcitol? Our experience in advanced chronic kidney disease.Nefrologia. 2012 May 14;32(3):401-2. doi: 10.3265/Nefrologia.pre2012.Feb.11378.
Title: Piao SG, Song JC, Lim SW, Chung BH, Choi BS, Yang CW.Protective effect of paricalcitol on cyclosporine-induced renal injury in rats.Transplant Proc. 2012 Apr;44(3):642-5.